These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32775268)

  • 1. Breast-conserving therapy is safe both within
    Huang X; Cai XY; Liu JQ; Hao WW; Zhou YD; Wang X; Xu Y; Chen C; Lin Y; Wang CJ; Song Y; Sun Q
    Gland Surg; 2020 Jun; 9(3):775-787. PubMed ID: 32775268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
    van den Broek AJ; Schmidt MK; van 't Veer LJ; Oldenburg HSA; Rutgers EJ; Russell NS; Smit VTHBM; Voogd AC; Koppert LB; Siesling S; Jobsen JJ; Westenend PJ; van Leeuwen FE; Tollenaar RAEM
    Ann Surg; 2019 Aug; 270(2):364-372. PubMed ID: 29727326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
    Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants.
    Liu X; Wang Y; Cao K; Yao L; Hu L; Sun J; Zhang J; Xu Y; Xie Y
    Breast Cancer Res Treat; 2023 May; 199(1):25-33. PubMed ID: 36930346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study.
    He X; Ji J; Qdaisat A; Esteva FJ; Yeung SJ
    Lancet Reg Health Am; 2024 Apr; 32():100712. PubMed ID: 38495316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
    Pierce LJ; Phillips KA; Griffith KA; Buys S; Gaffney DK; Moran MS; Haffty BG; Ben-David M; Kaufman B; Garber JE; Merajver SD; Balmaña J; Meirovitz A; Domchek SM
    Breast Cancer Res Treat; 2010 Jun; 121(2):389-98. PubMed ID: 20411323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
    Nilsson MP; Hartman L; Kristoffersson U; Johannsson OT; Borg A; Henriksson K; Lanke E; Olsson H; Loman N
    Breast Cancer Res Treat; 2014 Oct; 147(3):571-8. PubMed ID: 25187270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.
    Wang C; Lin Y; Zhu H; Zhou Y; Mao F; Huang X; Zhou X; Cao X; Sun Q
    Breast Cancer; 2022 Mar; 29(2):314-323. PubMed ID: 34766244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
    Cao W; Xie Y; He Y; Li J; Wang T; Fan Z; Fan T; Ouyang T
    Breast Cancer Res Treat; 2019 Jun; 175(3):749-754. PubMed ID: 30895535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with
    Emiroglu S; Özkurt E; Cabıoglu N; Igci A; Saip P; Yazici H; Ozmen T; Ozmen V; Muslumanoglu M; Tukenmez M
    Breast Cancer (Dove Med Press); 2023; 15():163-173. PubMed ID: 36852260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation Carriers.
    Bernstein-Molho R; Laitman Y; Galper S; Jacobson G; Boursi B; Gal-Yam EN; Kaufman B; Friedman E; Kaidar-Person O
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1332-1340. PubMed ID: 33259931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy should be considered for clinically node-negative breast cancer regardless of
    Huang X; Liu JQ; Zhou YD; Xu Y; Chen C; Wang X; Cao X; Yao R; Sun Q
    Ann Transl Med; 2020 Sep; 8(18):1183. PubMed ID: 33241032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.
    Vallard A; Magné N; Guy JB; Espenel S; Rancoule C; Diao P; Deutsch E; Rivera S; Chargari C
    Br J Radiol; 2019 May; 92(1097):20170657. PubMed ID: 30810334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.
    Davey MG; Davey CM; Ryan ÉJ; Lowery AJ; Kerin MJ
    Breast; 2021 Apr; 56():26-34. PubMed ID: 33582622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis.
    Ji J; Yuan S; He J; Liu H; Yang L; He X
    Cancer Med; 2022 Apr; 11(7):1646-1658. PubMed ID: 35212160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study.
    Wang S; Zhang Y; Yin F; Wang X; Yang Z
    Front Oncol; 2021; 11():741737. PubMed ID: 34790571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.
    Ye F; Huang L; Lang G; Hu X; Di G; Shao Z; Cao A
    Cancer Med; 2020 Mar; 9(5):1903-1910. PubMed ID: 31912664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study.
    Yuan YW; Liu PC; Li FF; Yang YH; Yang W; Fan L; Mou DW; Yang HW; Chen MS
    BMC Surg; 2023 Oct; 23(1):298. PubMed ID: 37789365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.